Evidence map›Paper›PMID 40563234›Full record

ArticleACS biomaterials science & engineering2025

Electrospun PCL Mats Modified with Magnetic Nanoparticles and Tannic Acid with Antibacterial and Possible Antiosteosarcoma Activity for Bone Tissue Engineering and Cancer Treatment.

Anna Hlukhaniuk, Małgorzata Świętek, Vitalii Patsula, Olga Janoušková, Antonín Brož, Marina Malić, Anna Kołodziej, Aleksandra Wesełucha-Birczyńska, Jiří Hodan, Miroslav Slouf and 6 more

Abstract read
In one paragraph

Article in ACS biomaterials science & engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Anna HlukhaniukInstitute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 162 06 Prague, Czech Republic.
Małgorzata ŚwiętekInstitute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 162 06 Prague, Czech Republic.ORCID 0000-0002-7800-5130
Vitalii PatsulaInstitute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 162 06 Prague, Czech Republic.
Olga JanouškováJan Evangelista Purkyně University in Ústí nad Labem, Faculty of Science, Pasteurova 3544/1, 400 96 Ústí nad Labem, Czech Republic.
Antonín BrožInstitute of Physiology, Czech Academy of Sciences, Vídeňská 1083, 142 00 Prague, Czech Republic.
Marina MalićInstitute of Physiology, Czech Academy of Sciences, Vídeňská 1083, 142 00 Prague, Czech Republic.
Anna KołodziejJagiellonian University, Faculty of Chemistry, Gronostajowa 2, 30-387 Krakow, Poland.
Aleksandra Wesełucha-BirczyńskaJagiellonian University, Faculty of Chemistry, Gronostajowa 2, 30-387 Krakow, Poland.
Jiří HodanInstitute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 162 06 Prague, Czech Republic.
Miroslav SloufInstitute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 162 06 Prague, Czech Republic.ORCID 0000-0003-1528-802X
Waldemar TokarzAGH University of Science and Technology, Faculty of Physics and Applied Computer Science, Mickiewicza 30, 30-059 Krakow, Poland.
Beata ZasońskaInstitute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 162 06 Prague, Czech Republic.
Lukáš BystrianskýJan Evangelista Purkyně University in Ústí nad Labem, Faculty of Science, Pasteurova 3544/1, 400 96 Ústí nad Labem, Czech Republic.
Milan GryndlerJan Evangelista Purkyně University in Ústí nad Labem, Faculty of Science, Pasteurova 3544/1, 400 96 Ústí nad Labem, Czech Republic.
Lucie BačákováInstitute of Physiology, Czech Academy of Sciences, Vídeňská 1083, 142 00 Prague, Czech Republic.ORCID 0000-0002-1818-9484
Daniel HorákInstitute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 162 06 Prague, Czech Republic.ORCID 0000-0002-6907-9701

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Modifying scaffolds with agents that at the same time positively influence osteogenic cells and have a negative impact on cancerous growth, is a promising solution for patients with bone tissue defects following tumor excision. Such materials may not only boost tissue regeneration but also limit the risk of cancer reoccurrence. In our study, we developed novel bifunctional scaffolds containing magnetic nanoparticles grafted with PCL (MNP@PCL) and tannic acid (TA), which may be directed to support normal bone cells and suppress osteosarcoma cells. First, MNPs were postsynthetically surface-modified, by grafting poly(ε-caprolactone) (PCL) from the surface via ring opening polymerization of ε-caprolactone, to provide their uniform distribution within the polymer matrix. Then, fiber mats containing a fixed amount of MNPs (2 wt %) and increasing content of TA (0, 1, 5, and 10 wt %) were prepared by electrospinning method. Both MNP@PCL and TA decreased polymer crystallinity. The interaction between the MNPs and TA significantly influenced the mat morphology, thermal properties, and initial hydrolytic performance. The most intensive TA release was observed mainly within first 6 h of incubation, and it was 3.5-fold higher (ca. 0.02 mg of TA/per mg of mat) for mfPCL@TA-10 compared to mfPCL@TA-5. Moreover, TA-containing magnetic mats suppressed the metabolic activity of osteosarcoma cells. They also demonstrated enhanced antimicrobial properties against the bacteria typically accompanying orthopedic complications, reducing the population of Gram-positive bacteria by more than 90% compared to the neat PCL mat. This proves the high potential of these materials for combining cancer treatment with bone tissue engineering.

Indexed as

Anti-Bacterial AgentsAntineoplastic AgentsBone NeoplasmsMagnetite NanoparticlesOsteosarcomaPolyestersTanninsTissue EngineeringBone and BonesCell Line, TumorHumansPolyphenolsTissue ScaffoldsAnti-Bacterial AgentsAntineoplastic AgentsMagnetite NanoparticlespolycaprolactonePolyestersPolyphenolstannic acidTanninsantibacterialbone regenerationfiber scaffoldsmagnetic nanoparticlesnanocompositestannic acid

Identifiers

PMID40563234
PMCPMC12264861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.